Development of a diagnostic test (ELISA) to detect antibodies against tumour antigen NY-ESO-1 (Q3313607): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: translated_label) |
(Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string) |
||
| Property / beneficiary | |||
| Property / beneficiary: Q3375280 / rank | |||
Normal rank | |||
Revision as of 15:59, 26 October 2021
Project Q3313607 in Germany
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Development of a diagnostic test (ELISA) to detect antibodies against tumour antigen NY-ESO-1 |
Project Q3313607 in Germany |
Statements
347,150.02 Euro
0 references
433,937.52 Euro
0 references
80.0 percent
0 references
11 January 2018
0 references
30 April 2021
0 references
Adversis Pharma GmbH
0 references
51°20'26.27"N, 12°22'29.03"E
0 references
Entwicklung eines diagnostischen Tests (ELISA) zum Nachweis von Antikörpern gegen das Tumorantigen NY-ESO-1 (German)
0 references
Development of a diagnostic test (ELISA) to detect antibodies against tumour antigen NY-ESO-1 (English)
25 October 2021
0 references
Leipzig, Stadt
0 references
Identifiers
672 / 101003528841
0 references